Patent №
US 10,156,575
Granted
2018-12-18
Filed 2017
Owner
20/20 GENESYSTEMS, INC.
Lab
—
AI components
1
kr
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15483218
A method of data interpretation from a multiplex cancer assay is described. The aggregate normalized score from the assay is transformed to a quantitative risk score quantifying a human subject's increased risk for the presence of cancer as compared to the known prevalence of the cancer in the population before testing the subject.
AI classification
Ownership
20/20 GENESYSTEMS, INC.
assignment · 474750094
Assignors
SHORE, RONALD, LEBOWITZ, MICHAEL
On an employer assignment, the assignors are typically the inventors.